Innovations in Drug Delivery Systems in Regenerative Medicine

Edited by:

Rakesh Bhaskar, PhD, Yeungnam University, Republic of Korea
Kannan Badri Narayanan, PhD, Yeungnam University, Republic of Korea
Tanveer Ahmad Mir, PhD, King Faisal Specialist Hospital and Research Centre, Saudi Arabia

Submission Status: Open | Submission Deadline: 2 September 2025

BioMedical Engineering OnLine is calling for submissions to our Collection on Innovations in Drug Delivery Systems in Regenerative Medicine.

Key Areas of Focus:
•   Nano-based Drug Delivery Systems
•   Biocompatible Materials for Drug Delivery
•   Polymeric Drug Carriers
•   3D Printing of Drug Delivery Devices
•   Scaffold-based Delivery Systems
•   Targeted Delivery to Specific Sites
•   Controlled and Sustained Release Mechanisms
•   Integration of Drug Delivery with Regenerative Medicine
•   Biodegradable Carriers for Drug Delivery
•   Smart Drug Delivery Systems

Image credit: © ArtemisDiana / Stock.adobe.com

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Submit to Collection

About the Collection

The Collection on Innovations in Drug Delivery Systems aims to showcase groundbreaking advancements in drug delivery technologies, emphasizing strategies that enhance precision, efficacy, and patient safety in therapeutic applications. This issue will cover various innovative approaches, including nanotechnology-based strategies that are revolutionizing the field by offering highly targeted, controlled drug delivery options. A central focus is on nano-based delivery systems, such as exosomes, dendrimers, polymeric nanoparticles, liposomes, and other nano-carriers. These nanoscale systems enable highly targeted delivery to specific cells or tissues, reducing off-target effects and enhancing therapeutic impact. Exosomes, for example, provide natural, biocompatible carriers that can deliver drugs directly to cellular targets, while dendrimers offer a versatile, highly branched structure for precise drug loading and release. Polymeric nanoparticles and liposomes are also explored for their ability to encapsulate drugs, ensuring controlled and sustained release, which improves bioavailability and therapeutic efficiency. Beyond nano-based systems, the issue will explore advancements in biocompatible materials, 3D-printed drug delivery devices, and scaffold-based systems that support both drug delivery and tissue regeneration. Integrating these technologies with regenerative medicine opens new possibilities for holistic, patient-centered care. This Special Issue aims to highlight these transformative developments that promise to reshape therapeutic precision and outcomes across diverse medical fields.

Key Areas of Focus:
•   Nano-based Drug Delivery Systems
•   Biocompatible Materials for Drug Delivery
•   Polymeric Drug Carriers
•   3D Printing of Drug Delivery Devices
•   Scaffold-based Delivery Systems
•   Targeted Delivery to Specific Sites
•   Controlled and Sustained Release Mechanisms
•   Integration of Drug Delivery with Regenerative Medicine
•   Biodegradable Carriers for Drug Delivery
•   Smart Drug Delivery Systems

Meet the Guest Editors

Back to top

Rakesh Bhaskar, PhD, Yeungnam University, Republic of Korea

Dr. Rakesh Bhaskar is an accomplished Assistant Professor at the Research Institute of Cell Culture and School of Chemical Engineering, Yeungnam University, South Korea. He earned his Ph.D. in Neuroendocrinology from Allahabad University, India, and advanced his expertise during a postdoctoral fellowship at NIT Rourkela, focusing on tissue engineering and regenerative medicine. His prolific research career includes over 80 publications in prestigious SCI/SCIE journals and five patents. Dr. Bhaskar has been working on spearheading innovative research projects on innovative drug delivery, stem cells, neuroscience, tissue engineering, and regenerative medicine. His groundbreaking work in regenerative medicine has expanded scientific understanding and laid the foundation for novel healthcare solutions.

Kannan Badri Narayanan, PhD, Yeungnam University, Republic of Korea

Dr. Kannan Badri Narayanan is an Assistant Professor with over a decade of expertise in biological sciences at the School of Chemical Engineering, Yeungnam University, South Korea. His research focuses on nanobiotechnology, antimicrobial nanocomposites, proteomics, phage therapy, biomimetics, biomaterials, and regenerative medicine.

Tanveer Ahmad Mir, PhD, King Faisal Specialist Hospital and Research Centre, Saudi Arabia

Dr. Tanveer Ahmad Mir is a Full Scientist and the principal investigator of the Laboratory of Tissue/Organ Bioengineering and BioMEMS at the Transplant Research & Innovation (Dpt)-R, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. His research is at the interface of biology, tissue/organoids bioengineering, bioprinting, biodegradable polymeric scaffolds/hydrogels, drug delivery, micro-nano biosensors and minimally invasive implantation.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Innovations in Drug Delivery Systems in Regenerative Medicine" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.